191 related articles for article (PubMed ID: 36698156)
1. The utility of texture analysis based on quantitative synthetic magnetic resonance imaging in nasopharyngeal carcinoma: a preliminary study.
Yang F; Li Y; Li X; Yu X; Zhao Y; Li L; Xie L; Lin M
BMC Med Imaging; 2023 Jan; 23(1):15. PubMed ID: 36698156
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the feasibility of synthetic MRI in the differential diagnosis of non-keratinising nasopharyngeal carcinoma and benign hyperplasia using different contoured methods for delineation of the region of interest.
Meng T; He H; Liu H; Lv X; Huang C; Zhong L; Liu K; Qian L; Ke L; Xie C
Clin Radiol; 2021 Mar; 76(3):238.e9-238.e15. PubMed ID: 33213835
[TBL] [Abstract][Full Text] [Related]
3. Synthetic MRI quantitative parameters in discriminating stage T1 nasopharyngeal carcinoma and benign hyperplasia: Combination with morphological features.
Zhang H; Zhao J; Dai J; Chang J; Hu S; Wang P
Eur J Radiol; 2024 Jan; 170():111264. PubMed ID: 38103492
[TBL] [Abstract][Full Text] [Related]
4. Synthetic MRI and diffusion-weighted imaging for differentiating nasopharyngeal lymphoma from nasopharyngeal carcinoma: combination with morphological features.
Zhang H; Hu L; Qin F; Chang J; Zhong Y; Dou W; Hu S; Wang P
Br J Radiol; 2024 May; ():. PubMed ID: 38733577
[TBL] [Abstract][Full Text] [Related]
5. Histogram analysis of quantitative parameters from synthetic MRI: correlations with prognostic factors in nasopharyngeal carcinoma.
Yang F; Li X; Li Y; Lei H; Du Q; Yu X; Li L; Zhao Y; Xie L; Lin M
Eur Radiol; 2023 Aug; 33(8):5344-5354. PubMed ID: 37036478
[TBL] [Abstract][Full Text] [Related]
6. Convolutional neural network for discriminating nasopharyngeal carcinoma and benign hyperplasia on MRI.
Wong LM; King AD; Ai QYH; Lam WKJ; Poon DMC; Ma BBY; Chan KCA; Mo FKF
Eur Radiol; 2021 Jun; 31(6):3856-3863. PubMed ID: 33241522
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.
Yu JY; Zhang D; Huang XL; Ma J; Yang C; Li XJ; Xiong H; Zhou B; Liao RK; Tang ZY
J Med Syst; 2020 Feb; 44(4):75. PubMed ID: 32103352
[TBL] [Abstract][Full Text] [Related]
8. Quantitative T1ρ MRI of the Head and Neck Discriminates Carcinoma and Benign Hyperplasia in the Nasopharynx.
Ai QYH; Chen W; So TY; Lam WKJ; Jiang B; Poon DMC; Qamar S; Mo FKF; Blu T; Chan Q; Ma BBY; Hui EP; Chan KCA; King AD
AJNR Am J Neuroradiol; 2020 Dec; 41(12):2339-2344. PubMed ID: 33122214
[TBL] [Abstract][Full Text] [Related]
9. Investigating the value of arterial spin labeling and intravoxel incoherent motion imaging on diagnosing nasopharyngeal carcinoma in T1 stage.
Li Y; Li X; Yu X; Lin M; Ouyang H; Xie L; Shang Y
Cancer Imaging; 2020 Aug; 20(1):62. PubMed ID: 32859273
[TBL] [Abstract][Full Text] [Related]
10. Synthetic MRI in differentiating benign from metastatic retropharyngeal lymph node: combination with diffusion-weighted imaging.
Wang P; Hu S; Wang X; Ge Y; Zhao J; Qiao H; Chang J; Dou W; Zhang H
Eur Radiol; 2023 Jan; 33(1):152-161. PubMed ID: 35951044
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.
Song C; Cheng P; Cheng J; Zhang Y; Sun M; Xie S; Zhang X
Eur Radiol; 2020 Jan; 30(1):110-118. PubMed ID: 31372786
[TBL] [Abstract][Full Text] [Related]
12. Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRI.
Ai QY; King AD; Chan JSM; Chen W; Chan KCA; Woo JKS; Zee BCY; Chan ATC; Poon DMC; Ma BBY; Hui EP; Ahuja AT; Vlantis AC; Yuan J
Eur Radiol; 2019 Oct; 29(10):5627-5634. PubMed ID: 30903340
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma.
Mao J; Fang J; Duan X; Yang Z; Cao M; Zhang F; Lu L; Zhang X; Wu X; Ding Y; Shen J
Eur Radiol; 2019 Aug; 29(8):4105-4113. PubMed ID: 30617473
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI.
Meng T; He N; He H; Liu K; Ke L; Liu H; Zhong L; Huang C; Yang A; Zhou C; Qian L; Xie C
Cancer Imaging; 2020 Dec; 20(1):88. PubMed ID: 33317609
[TBL] [Abstract][Full Text] [Related]
16. Can Arterial Spin Labeling Perfusion Imaging be Used to Differentiate Nasopharyngeal Carcinoma From Nasopharyngeal Lymphoma?
Sun Z; Hu S; Ge Y; Jin L; Huang J; Dou W
J Magn Reson Imaging; 2021 Apr; 53(4):1140-1148. PubMed ID: 33225524
[TBL] [Abstract][Full Text] [Related]
17. Differentiation between nasopharyngeal carcinoma and lymphoma at the primary site using whole-tumor histogram analysis of apparent diffusion coefficient maps.
Lian S; Zhang C; Chi J; Huang Y; Shi F; Xie C
Radiol Med; 2020 Jul; 125(7):647-653. PubMed ID: 32072391
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of diffusion-weighted magnetic resonance imaging for local and skull base recurrence of nasopharyngeal carcinoma after radiotherapy.
Wang C; Liu L; Lai S; Su D; Liu Y; Jin G; Zhu X; Luo N
Medicine (Baltimore); 2018 Aug; 97(34):e11929. PubMed ID: 30142809
[TBL] [Abstract][Full Text] [Related]
19. Radiomic analysis of MRI for prediction of response to induction chemotherapy in nasopharyngeal carcinoma patients.
Wang A; Xu H; Zhang C; Ren J; Liu J; Zhou P
Clin Radiol; 2023 Sep; 78(9):e644-e653. PubMed ID: 37331848
[TBL] [Abstract][Full Text] [Related]
20. Dual-energy CT in the differentiation of stage T1 nasopharyngeal carcinoma and lymphoid hyperplasia.
Wang P; Xiao Z; Tang Z; Wang J
Eur J Radiol; 2020 Mar; 124():108824. PubMed ID: 31954331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
